KYZATREX 150 MG Oral Capsule

RxCUI: 2609607
RxNorm name: KYZATREX 150 MG Oral Capsule
Display name: KYZATREX 150 MG Oral Capsule
Full name: KYZATREX 150 MG Oral Capsule
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Kyzatrex	TESTOSTERONE UNDECANOATE	Marius Pharmaceuticals	7f7167a7-2a25-47e2-acf5-33f499fce971	2026-08-26	Warnings, Adverse reactions	Exact identifier rxcui: 2609607

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
7f7167a7-2a25-47e2-acf5-33f499fce971	KYZATREX 150 MG Oral Capsule [PSN] · testosterone undecanoate 150 MG Oral Capsule [Kyzatrex] [SBD] · Kyzatrex 150 MG Oral Capsule [SY]	3	22	These highlights do not include all the information needed to use KYZATREX® safely and effectively. See full prescribing information for KYZATREX®. KYZATREX® (testosterone undecanoate) capsules, for oral use, CIII Initial U.S. approval: 1953	20251015